MPS Acquisition
MPS Limited informed the exchange that the NCLT has passed an order regarding the second motion petition for its amalgamation with ADI BPO Services Limited.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements
MPS Limited informed the exchange that the NCLT has passed an order regarding the second motion petition for its amalgamation with ADI BPO Services Limited.
MPS Limited has received an unsolicited 'CRISIL ESG 64 (Strong)' rating from CRISIL ESG, based on publicly available data without company engagement.
MPS Limited conducted its 56th Annual General Meeting on September 4, 2026. This document provides the summary of proceedings and resolutions discussed during the meeting.
MPS delivers record Q1 FY27 results, leveraging high operating leverage and AI integration to drive EBITDA growth significantly faster than revenue.
MPS reports record Q1 FY27 results with 20.38% revenue growth and 53.03% EBITDA surge, driven by the Unbound Medicine acquisition and AI-enabled workflows.
MPS Ltd reported revenue from operations of ₹224.2 Cr (+20.3% YoY) and net profit of ₹50.4 Cr (+43.2% YoY) for Q1 FY27.
MPS Limited reports FY26 as its most profitable year, driven by AI-led knowledge solutions and the acquisition of Unbound Medicine.
MPS closed FY26 with record profitability, driven by its transformation into an AI-first knowledge solutions provider and the successful integration of Unbound Medicine.
MPS Limited reported record FY26 EPS of ₹102.11 (+16.3% YoY) with consolidated EBITDA of ₹236 Cr (30.7% margin), driven by an AI-first strategy and the Unbound Medicine acquisition.
MPS Ltd reported revenue from operations of ₹205.2 Cr (+12.7% YoY) and net profit of ₹47 Cr (-0.2% YoY) for Q4 FY26.